These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37099824)

  • 1. Relationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy.
    Casas-Alba D; Aguilar A; Alonso I; García MT; Cilio MR; Fons C;
    Pediatr Neurol; 2023 Jul; 144():11-15. PubMed ID: 37099824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic analysis of 18 patients with
    Cao B; Peng B; Tian Y; Wang X; Li X; Zhu H; Shen H; Chen W
    Turk J Pediatr; 2024 May; 66(2):191-204. PubMed ID: 38814296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy.
    Knight D; Mahida S; Kelly M; Poduri A; Olson HE
    Epilepsia; 2023 Jul; 64(7):e143-e147. PubMed ID: 37096745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of KCNQ2 encephalopathy.
    Kim HJ; Yang D; Kim SH; Won D; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2021 Feb; 43(2):244-250. PubMed ID: 32917465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capturing seizures in clinical trials of antiseizure medications for
    Millichap JJ; Harden CL; Dlugos DJ; French JA; Butterfield NN; Grayson C; Aycardi E; Pimstone SN
    Epilepsia Open; 2021 Mar; 6(1):38-44. PubMed ID: 33681646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genotype and phenotype of children with KCNA2 gene related developmental and epileptic encephalopathy].
    Gong P; Xue J; Jiao XR; Zhang YH; Yang ZX
    Zhonghua Er Ke Za Zhi; 2020 Jan; 58(1):35-40. PubMed ID: 31905474
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics of 80 subjects with KCNQ2-related encephalopathy: Results from a family-driven survey.
    Cossu A; Lo Barco T; Proietti J; Dalla Bernardina B; Cantalupo G; Ghobert L; Brambilla I; Giarola E; Costa A; De Benito T; Bethge S; Cardot S; Montwill I; Remonato E; Gramaglia S; Darra F
    Epilepsy Behav; 2023 May; 142():109153. PubMed ID: 36989566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and effective treatment of KCNQ2 encephalopathy.
    Pisano T; Numis AL; Heavin SB; Weckhuysen S; Angriman M; Suls A; Podesta B; Thibert RL; Shapiro KA; Guerrini R; Scheffer IE; Marini C; Cilio MR
    Epilepsia; 2015 May; 56(5):685-91. PubMed ID: 25880994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review.
    Falsaperla R; Criscione R; Cimino C; Pisani F; Ruggieri M
    Neuropediatrics; 2023 Oct; 54(5):297-307. PubMed ID: 36948217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis and functional characterization of KCNQ2-related developmental and epileptic encephalopathy.
    Ye J; Tang S; Miao P; Gong Z; Shu Q; Feng J; Li Y
    Front Mol Neurosci; 2023; 16():1205265. PubMed ID: 37497102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.
    Lee IC; Chang TM; Liang JS; Li SY
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00816. PubMed ID: 31199083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNQ2 related early-onset epileptic encephalopathies in Chinese children.
    Fang ZX; Zhang M; Xie LL; Jiang L; Hong SQ; Li XJ; Hu Y; Chen J
    J Neurol; 2019 Sep; 266(9):2224-2232. PubMed ID: 31152295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-induced seizures in a mouse model of KCNQ2-NEO-DEE.
    Brun L; Borloz E; Felix MS; Louis Durand J; Villard L
    Epilepsy Res; 2023 Jul; 193():107160. PubMed ID: 37187037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNQ2 mutations cause unique neonatal behavior arrests without motor seizures: Functional characterization.
    Wong SH; Liou YM; Yang JJ; Lee IC
    Epilepsy Behav; 2024 Jul; 156():109798. PubMed ID: 38788659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy.
    Ko A; Youn SE; Kim SH; Lee JS; Kim S; Choi JR; Kim HD; Lee ST; Kang HC
    Epilepsy Res; 2018 Mar; 141():48-55. PubMed ID: 29455050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNQ2-DEE: developmental or epileptic encephalopathy?
    Berg AT; Mahida S; Poduri A
    Ann Clin Transl Neurol; 2021 Mar; 8(3):666-676. PubMed ID: 33616268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.
    Beck VC; Isom LL; Berg AT
    J Pediatr; 2021 Oct; 237():41-49.e1. PubMed ID: 34181986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.